How much funding has Gentian raised?

Gentian has raised $1.6M in total funding, most recently a Pre-Seed round.

Who are Gentian's investors?

Gentian's investors include Ecolab, Techstars, Blu Venture Investors, gener8tor, Pax Momentum.

Where is Gentian headquartered?

Gentian is headquartered in London, United Kingdom.

What industry is Gentian in?

Gentian operates in Artificial Intelligence.

Gentian

Efficient diagnostics for better treatment decisions

London, United Kingdom · Founded 2023 · $1.6M raised

Artificial Intelligence

Headquarters: London
Employees: 51–200
Founded: 2023
Business Model: B2B

Website: gentian.io
Total Funding: $1.6M
Last Round: $1.6M Pre-SeedDec 2023
Rounds: 1

About

Gentian Diagnostics ASA is a publicly listed Norwegian in vitro diagnostics (IVD) company that develops and manufactures high-quality diagnostic reagents and test kits for use on clinical chemistry analysers. Founded in 1996 and headquartered in Moss, Norway, the company focuses on particle-enhanced turbidimetric immunoassay (PETIA) technology that enables efficient, automated testing on standard laboratory equipment. Its product portfolio covers kidney disease (Cystatin C, RBP), cardiac disease (NT-proBNP), inflammation and infection (Calprotectin/GCAL), and veterinary diagnostics (Canine CRP). Gentian serves the global market through OEM partnerships and distributors, and also operates regional entities in the Nordics, North America, and China.

Summary

Gentian is an Artificial Intelligence company based in London, United Kingdom, founded in 2023. It has raised $1.6M in total across 1 round, most recently a $1.6M Pre-Seed round in Dec 2023. Investors include Ecolab, Techstars and Blu Venture Investors.